Endothelin-1 induces contraction of female rat internal pudendal and clitoral arteries through ETA receptor and rho-kinase activation

Journal of Sexual Medicine

Volumn 7, Issue 6, 2010, Pages 2096-2103

  Allahdadi, Kyan J ^a   Hannan, Johanna L ^a   Tostes, Rita C ^a,b   Webb, R Clinton ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Clitoral Artery; Endothelin 1; Internal Pudendal Artery; Rho Kinase

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ATRASENTAN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; MESSENGER RNA; POTASSIUM CHLORIDE; PROTEIN PRECURSOR; RHO KINASE; RHO KINASE INHIBITOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL TISSUE; ARTERY; ARTERY CONSTRICTION; ARTICLE; BLOOD FLOW; CLITORIS ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUDENDAL ARTERY; RAT; REAL TIME POLYMERASE CHAIN REACTION; SEXUAL AROUSAL; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

EID: 77953933815     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.01816.x     Document Type: Article

References (45)

1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999, 281:537-44.
2. Min K, O'Connell L, Munarriz R, Huang YH, Choi S, Kim N, Goldstein I, Traish A. Experimental models for the investigation of female sexual function and dysfunction. Int J Impot Res 2001, 13:151-6.
3. Berman JR, Berman L, Goldstein I. Female sexual dysfunction: Incidence, pathophysiology, evaluation, and treatment options. Urology 1999, 54:385-91.
4. Carson CC, Lue TF. Phosphodiesterase type 5 inhibitors for erectile dysfunction. BJU Int 2005, 96:257-80.
5. Phillips NA. Female sexual dysfunction: Evaluation and treatment. Am Fam Physician 2000, 62:127-36.
6. Masaki T. The discovery, the present state, and the future prospects of endothelin. J Cardiovasc Pharmacol 1989, 13(5):S1-4. suppl, discussion S18
7. Hemsen A, Larsson O, Lundberg JM. Characteristics of endothelin A and B binding sites and their vascular effects in pig peripheral tissues. Eur J Pharmacol 1991, 208:313-22.
8. Hemsen A. Biochemical and functional characterization of endothelin peptides with special reference to vascular effects. Acta Physiol Scand Suppl 1991, 602:1-61.
9. Christ GJ, Lerner SE, Kim DC, Melman A. Endothelin-1 as a putative modulator of erectile dysfunction: I. Characteristics of contraction of isolated corporal tissue strips. J Urol 1995, 153:1998-2003.
10. Ihara M, Saeki T, Funabashi K, Nakamichi K, Yano M, Fukuroda T, Miyaji M, Nishikibe M, Ikemoto F. Two endothelin receptor subtypes in porcine arteries. J Cardiovasc Pharmacol 1991, 17(7):S119-21. suppl
11. Bell CR, Sullivan ME, Dashwood MR, Muddle JR, Morgan RJ. The density and distribution of endothelin 1 and endothelin receptor subtypes in normal and diabetic rat corpus cavernosum. Br J Urol 1995, 76:203-7.
12. Fleming IN, Elliott CM, Exton JH. Differential translocation of rho family GTPases by lysophosphatidic acid, endothelin-1, and platelet-derived growth factor. J Biol Chem 1996, 271:33067-73.
13. Bivalacqua TJ, Champion HC, Usta MF, Cellek S, Chitaley K, Webb RC, Lewis RL, Mills TM, Hellstrom WJ, Kadowitz PJ. RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: A mechanism for diabetes-associated erectile dysfunction. Proc Natl Acad Sci U S A 2004, 101:9121-6.
14. Wilkes N, White S, Stein P, Bernie J, Rajasekaran M. Phosphodiesterase-5 inhibition synergizes rho-kinase antagonism and enhances erectile response in male hypertensive rats. Int J Impot Res 2004, 16:187-94.
15. Kanagy NL, Walker BR, Nelin LD. Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension 2001, 37:511-5.
16. Ergul A, Jupin D, Johnson MH, Prisant LM. Elevated endothelin-1 levels are associated with decreased arterial elasticity in hypertensive patients. J Clin Hypertens (Greenwich) 2006, 8:549-54.
17. Allahdadi KJ, Walker BR, Kanagy NL. Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 2005, 45:705-9.
18. Carneiro FS, Nunes KP, Giachini FR, Lima VV, Carneiro ZN, Nogueira EF, Leite R, Ergul A, Rainey WE, Clinton Webb R, Tostes RC. Activation of the ET-1/ETA Pathway Contributes to Erectile Dysfunction Associated with Mineralocorticoid Hypertension. J Sex Med 2008, 5:2793-807.
19. Carneiro FS, Giachini FR, Lima VV, Carneiro ZN, Nunes KP, Ergul A, Leite R, Tostes RC, Webb RC. DOCA-salt treatment enhances responses to endothelin-1 in murine corpus cavernosum. Can J Physiol Pharmacol 2008, 86:320-8.
20. Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile dysfunction and subsequent cardiovascular disease. Jama 2005, 294:2996-3002.
21. Kostis JB, Jackson G, Rosen R, Barrett-Connor E, Billups K, Burnett AL, Carson C, Cheitlin M, Debusk R, Fonseca V, Ganz P, Goldstein I, Guay A, Hatzichristou D, Hollander JE, Hutter A, Katz S, Kloner RA, Mittleman M, Montorsi F, Montorsi P, Nehra A, Sadovsky R, Shabsigh R. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol 2005, 96:85M-93M.
22. Doumas M, Douma S. Sexual dysfunction in essential hypertension: Myth or reality? J Clin Hypertens 2006, 8:269-74.
23. Doumas M, Tsiodras S, Tsakiris A, Douma S, Chounta A, Papadopoulos A, Kanellakopoulou K, Giamarellou H. Female sexual dysfunction in essential hypertension: A common problem being uncovered. J Hypertens 2006, 24:2387-92.
24. Burri AV, Cherkas LM, Spector TD. The genetics and epidemiology of female sexual dysfunction: A review. J Sex Med 2009, 6:646-57.
25. Manolis A, Doumas M. Sexual dysfunction: The " prima ballerina" of hypertension-related quality-of-life complications. J Hypertens 2008, 26:2074-84.
26. Aboseif SR, Breza J, Orvis BR, Lue TF, Tanagho EA. Erectile response to acute and chronic occlusion of the internal pudendal and penile arteries. J Urol 1989, 141:398-402.
27. Park K, Goldstein I, Andry C, Siroky MB, Krane RJ, Azadzoi KM. Vasculogenic female sexual dysfunction: The hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency. Int J Impot Res 1997, 9:27-37.
28. Hubscher CH, Brooks DL, Johnson JR. A quantitative method for assessing stages of the rat estrous cycle. Biotech Histochem 2005, 80:79-87.
29. Thorin E, Webb DJ. Endothelium-derived endothelin-1. Pflugers Arch 2009, Dec 4 [Epub ahead of print] doi: 10.1007/s00424-009-0763-y
30. Schiffrin EL, Touyz RM. Vascular biology of endothelin. J Cardiovasc Pharmacol 1998, 32(3):S2-13. suppl
31. Myung SC, Lee MY, Lee SY, Yum SH, Park SH, Kim SC. Contractile changes of the clitoral cavernous smooth muscle in female rabbits with experimentally induced overactive bladder. J Sex Med 2008, 5:1088-96.
32. Cellek S. The Rho-kinase inhibitor Y-27632 and the soluble guanylyl cyclase activator BAY41-2272 relax rabbit vaginal wall and clitoral corpus cavernosum. Br J Pharmacol 2003, 138:287-90.
33. Park JK, Lee SO, Kim YG, Kim SH, Koh GY, Cho KW. Role of rho-kinase activity in angiotensin II-induced contraction of rabbit clitoral cavernosum smooth muscle. Int J Impot Res 2002, 14:472-7.
34. Parada M, Chamas L, Censi S, Coria-Avila G, Pfaus JG. Clitoral stimulation induces conditioned place preference and Fos activation in the rat. Horm Behav 2010, 57:112-8.
35. Gragasin FS, Michelakis ED, Hogan A, Moudgil R, Hashimoto K, Wu X, Bonnet S, Haromy A, Archer SL. The neurovascular mechanism of clitoral erection: Nitric oxide and cGMP-stimulated activation of BKCa channels. Faseb J 2004, 18:1382-91.
36. Bechara AJ, Cao G, Casabe AR, Romano SV, Toblli JE. Morphological modifications in clitoris and vagina in spontaneously hypertensive rats. Int J Impot Res 2003, 15:166-72.
37. Duncan LE, Lewis C, Jenkins P, Pearson TA. Does hypertension and its pharmacotherapy affect the quality of sexual function in women? Am J Hypertens 2000, 13:640-7.
38. Matsumoto T, Kakami M, Kobayashi T, Kamata K. Gender differences in vascular reactivity to endothelin-1 (1-31) in mesenteric arteries from diabetic mice. Peptides 2008, 29:1338-46.
39. Jernigan NL, Walker BR, Resta TC. Reactive oxygen species mediate RhoA/Rho kinase-induced Ca2+ sensitization in pulmonary vascular smooth muscle following chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 2008, 295:L515-29.
40. Doi T, Sakoda T, Akagami T, Naka T, Mori Y, Tsujino T, Masuyama T, Ohyanagi M. Aldosterone induces interleukin-18 through endothelin-1, angiotensin II, Rho/Rho-kinase, and PPARs in cardiomyocytes. Am J Physiol Heart Circ Physiol 2008, 295:H1279-H87.
41. Allahdadi KJ, Duling LC, Walker BR, Kanagy NL. Eucapnic intermittent hypoxia augments endothelin-1 vasoconstriction in rats: Role of PKCdelta. Am J Physiol Heart Circ Physiol 2008, 294:H920-7.
42. Abdel-Sayed S, Nussberger J, Aubert JF, Gohlke P, Brunner HR, Brakch N. Measurement of plasma endothelin-1 in experimental hypertension and in healthy subjects. Am J Hypertens 2003, 16:515-21.
43. Allahdadi KJ, Cherng TW, Pai H, Silva AQ, Walker BR, Nelin LD, Kanagy NL. Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia. Am J Physiol Heart Circ Physiol 2008, 295:H434-40.
44. Miyauchi T, Yanagisawa M, Tomizawa T, Sugishita Y, Suzuki N, Fujino M, Ajisaka R, Goto K, Masaki T. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 1989, 2:53-4.
45. Oishi S, Sasaki M, Sato T. Elevated immunoreactive endothelin levels in patients with pheochromocytoma. Am J Hypertens 1994, 7:717-22.